NCT07776015Completed
Exosome Injection Versus Topical Minoxidil for Androgenetic Alopecia
A Prospective, Randomized, Comparative Study of the Efficacy and Safety of Intradermal Exosome Injections Versus Topical Minoxidil in Patients With Androgenetic Alopecia
In the register
This trial is not attached to a programme in the register yet. Unattached trials are kept on purpose: they are where new programmes turn up first.
What the registry records
- Status
- Completed
- Declared phase
- Not applicable (NA in the registry)
- Sponsor
- Tanta University
- Participants (registry)
- 40
- Start
- April 2023
- Primary completion
- May 2024
- Study completion
- December 2025
- Last registry update
- August 2026
- Countries
- Egypt
Conditions studied: Androgenetic Alopecia, Exosomes
Interventions: exosomes injection, Topical Minoxidil 5%
Listing a trial is not a recommendation to join one. Eligibility, risks and costs vary enormously — discuss any trial with your own doctor first. A registration proves a sponsor declared a study, not that it is progressing or will succeed. We're not doctors.